THERMOREVERSIBLE IN-SITU NASAL GEL FORMULATIONS AND THEIR PHARMACEUTICAL EVALUATION FOR THE TREATMENT OF ALLERGIC RHINITIS CONTAINING EXTRACTS OF MORINGA OLIFERA AND EMBELIA RIBES
Objective: The present study was planned to develop thermo-reversible in-situ gel for the treatment of allergic rhinitis (AR). The objective of the present investigation was to develop a mucoadhesive in-situ gel with reduced nasal mucocilliary clearance to improve the local effect of the polyherbal extract in the treatment of allergic rhinitis (AR). The prolonged residence of drug formulation in the nasal cavity is one of utmost importance for intranasal drug delivery. The prepared formulations were subjected for gelling temperature, gelling time, viscosity, gel strength, pH, drug content, mucoadhesive strength, spread ability and irritancy studies.
Methods: In the study the pluronic F127 (PF127) based mucoadhesive in-situ nasal gels containing Moringa olifera (MO) and Embelia ribes (ER) extracts were used having antioxidant and anti-inflammatory effect. A polyherbal thermosensitive in-situ hydrogel was designed and evaluated by the mixing of pluronic F127, poly (ethylene glycol) (PEG400) and Xanthan gum with a small amount of (hydroxypropyl methylcellulose) HPMC K4M and Carbopol 934. Total 13 thermosensitive in-situ gels of extracts were prepared through combination of HPMC K4M or Carbopol or xanthan gum and PF127. All the preparations were investigated, and the selected method for gel formation underwent the thermal transition from sol to hydrogel.
Results: The mucoadhesive gel after being administered into the nasal cavity, get transformed into the viscous hydrogel at body temperature, which diminished nasal mucociliary clearance and prolonged the duration of action. The in-situ nasal herbal gel prepared by combination of different concentration of to HPMC K4M or carbopol or xanthan gum with PF127 (10% w/v) produces the better and effective gel. The findings of evaluation parameter indicate that the in-situ gel prepared by combination with corbopol were better quality compared to HPMC K4M and xanthan gum.
Conclusion: From these findings, it can be concluded that in-situ herbal nasal gels may be potential drug delivery systems for Moringa olifera and Embelia ribes extracts to overcome first-pass metabolism and thereby to improve the bioavailability. The mucoadhesive in-situ gel system is a promising approach for the intranasal delivery of polyherbal extracts for the therapeutic effects improvement of Allergic rhinitis.
2. Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001;108:S2â€“S8.
3. Capkova Z, Vitkova Z, Subova M. Formulation of loratadine into hydrogels. Acta Fac Pharm Univ Comenianae 2005;52:73â€“8.
4. Kisan RJ, Manoj NG, Ishaque MS, Vilarsrao JK, Sambjahi SP. Nasal drug delivery system-factors affecting and applicatins. Curr Drug Ther 2007;2:27â€“38.
5. Basu S, Bandyopadhyay AK. Development and characterization of mucoadhesive in-situ nasal gel of midazolam prepared with Ficus carica mucilage. AAPS PharmSciTech 2010;11:1223-31.
6. Swathi S. Phytochemical screening and TLC studies of Moringa oleifera extract: their antibacterial and anti-oxidant activities Int Curr Pharm Res 2015;1:46-9.
7. Pratibha N, Saxena VS, Amit A, D'souza P, Bagchi M, Bagchi D. Anti-inflammatory activities of Aller-7, a novel polyherbal formulation for allergic rhinitis. Int J Tissue Reactions 2003;26:43-51.
8. Krishnamoorthy R, Mitra AK. Prodrugs for nasal drug delivery. Adv Drug Delivery Rev 1998;29:135â€“46.
9. Hu G, Walls RS, Bass D, Bullock R, Grayson D, Jones M, et al. The Chinese herbal formulation biminne in management of perennial allergic rhinitis: a randomized, double-blind, placebo-controlled, 12-week clinical trial. Annals of Allergy, Asthma Immunol 2002;88:478-87.
10. Schmolka IR. Artificial skin: preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res 1972;6:571â€“82.
11. Sherafudeen SP, Vasantha PV. Development and evaluation of in-situ nasal gel formulations of loratadine. Res Pharm Sci 2015;10:466â€“76.
12. Gizurarson Sveinbjorn. Anatomical and histological factors affecting intranasal drug and vaccine delivery. Curr Drug Delivery 2012;9:566â€“82.
13. Bhalerao AV, Lonkar SL, Deshkar SS, Shirolkar SV, Deshpande AD. Nasal mucoadhesive in-situ gel of ondansetron hydrochloride. Indian J Pharm Sci 2009;71:711â€“3.
14. Miller SC, Donovan MD. Effect of poloxamer 407 gels on the miotic activity of pilocarpine nitrate in rabbits. Int J Pharm 1982;12:142â€“52.
15. Kumar MV, Aravindram AS, Rohitash K, Gowda DV, Parjanya K. Formulation and evaluation of in-situ gel of bromhexine hydrochloride for nasal delivery. Der Pharm Sinica 2012;3:699â€“707.
16. Shinde JV, Mali KR, Dias RJ, Havaldar VD, Mahajan NS. In-situ mucoadhesive nasal gels of metaclopramide hydrochloride: preformulation and formulation studies. J Pham Res 2008;1:88â€“96.
17. Li GL, Li M. Preparation and evaluation of ophthalmic thermosensitive in-situ gels of penciclovir. J Chin Pharm Sci 2007;16:90â€“5.
18. SchilleÂ´n K, Glatter O, Brown W. Characterization of a PEO-PPO-PEO block copolymer system. Progr Colloid Polym Sci 1993;93:66â€“71.
19. Mainardes RM, Urban MC, Cinto PO, Chaud MV, Evangelista RC, Gremiao MP. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. Curr Drug Delivery 2006;3:275â€“85.
20. Rana Abu-Huwaij, Rana M Obaidat, Kamal Sweidan, Yusuf Al-Hiari. Formulation and in vitro evaluation of xanthan gum or carbopol 934-based mucoadhesive patches, loaded with nicotine. AAPS PharmSciTech 2011;12:21â€“7.